Delivery Order 36F79724D0159-15B50526F00000181
Award Date 7/1/26
Potential Completion Date 9/30/26
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Titusville, Hopewell Township, NJ 08560, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Federal Correctional Institution Fort Worth issued a $61,988.37 delivery order to Actelion Pharmaceuticals US, Inc. on August 1, 2026, under the GSA Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, for Actelion pulmonary arterial hypertension medications (Uptravi and Opsumit) with an ultimate completion date of August 31, 2026. The FSS-61-IB schedule is a multiple-award vehicle valued at $219.1 million with a period of performance through July 31, 2029, enabling federal...
- Federal Medical Center Carswell issued a $12,853.56 delivery order to Actelion Pharmaceuticals US, Inc. on April 1, 2026, for Opsumit 10 mg (two units at $6,426.78 each), with completion by April 30, 2026. The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple-award schedule contract valued at $219.1 million with a period of performance from August 1, 2024, through July 31, 2029, funded by the Department of Veterans Affairs through Veterans...
- This is a firm fixed-price delivery order awarded by the Federal Medical Center Carswell, a civilian federal agency, to Actelion Pharmaceuticals US, Inc., a pharmaceutical manufacturer. The order is for the supply of critical medications used to treat pulmonary arterial hypertension, including Opsumit, Uptravi, and Adempas. The total ceiling value of the order is $72,226.86, with a period of performance through October 31, 2024. The award is placed against Actelion Pharmaceuticals' Federal...
- The U.S. Department of Veterans Affairs, through Federal Medical Center Carswell, awarded a $12.5K delivery order to Actelion Pharmaceuticals US, Inc. for the procurement of Opsumit (macitentan) 10 mg tablets, with a quantity of two units at $6,270.03 per unit. This firm fixed-price delivery order, issued on January 31, 2026, with an ultimate completion date of January 31, 2026, represents a direct pharmaceutical procurement with no small business set-aside designation. The order will be...
- This is a delivery order awarded by the Federal Medical Center Carswell, a civilian agency, to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The $1,349.96 firm-fixed-price contract is for the supply of Ambrisentan 10mg 30-count bottles, a medication used to treat pulmonary arterial hypertension. The contract was awarded under Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Actelion also holds a $60 million...
- This federal contract award was made by the Veterans Integrated Service Network 20, a civilian agency, to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The contract is for the delivery of the drug VELETRI, with a ceiling value of $65,499.96 and an ultimate completion date of September 30, 2026. The contract is a Firm Fixed Price Delivery Order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs, valued at...
- The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $54,303.72 delivery order contract to Actelion Pharmaceuticals US, Inc. for the supply of 30-count bottles of the pulmonary hypertension drug Opsumit (macitentan) 10mg. Actelion will deliver the medication under a firm fixed price arrangement by December 30, 2023 in performance of the Master GSA Schedule contract Pharmaceuticals and Drugs (FSS-61-IB). As the largest federal medical center operated by the Bureau...
- Federal Medical Center Carswell issued a delivery order to Actelion Pharmaceuticals US, Inc. on March 1, 2026, for $12,853.56 to procure Opsumit 10mg tablets (quantity 2 units at $6,426.78 each) under a firm fixed-price arrangement. The ultimate completion date is March 31, 2026. Opsumit is a specialized pharmaceutical treatment for pulmonary arterial hypertension that Actelion supplies to federal healthcare facilities, including correctional institutions and veterans' medical centers. This...
- The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $36,202.48 firm fixed price delivery order contract to Actelion Pharmaceuticals US, Inc. for the provision of 30-count bottles of the pharmaceutical CURASCRIPT, OPSUMIT 10MG to treat pulmonary arterial hypertension. Actelion will deliver the medication under the Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract, identified as Schedule 61-IB. Performance will occur from...
- This federal contract award, valued at $35,590.74, was issued to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, by the Federal Medical Center Carswell, a civilian agency. The award is a delivery order contract against Actelion's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, as well as a separate $60 million Blanket Purchase Agreement focused on pulmonary arterial hypertension therapies. The contract is for the supply of Adempas 1mg...